Comprehensive geriatric assessment as a predictor of complications in oncogeriatric patients
Abstract
Introduction: The Cuban population is considered to be aged, and aging is directly proportional to the occurrence of cancer. Elderly patients are more prone to presenting complications during the oncospecific treatment due to the physiological changes typical of their age. It is recommended to perform a comprehensive geriatric assessment of cancer patients aged over 70 years.
Objective: Describe the tools most commonly used for comprehensive geriatric assessment with the purpose of predicting complications during chemotherapy.
Methods: A review was conducted in PUBMED, SciELO and Lilacs using the key terms comprehensive geriatric assessment, oncogeriatrics, cancer. A total 50 articles were reviewed from which 37 were selected for being more directly related to the review topic.
Discussion: The importance of CGA for oncological patients is well known, but its application is still not systematic, possibly in relation to the time for its performance. The CGA includes several questionnaires applied to patients to collect fundamental information to determine the patient's frailty and take the corresponding decisions, as well as predict the possible complications of the chemotherapy treatment.
Conclusions: Awareness of the application of these tools makes it possible to predict the complications of oncological treatment that elderly patients may present, thus individualizing behavior.
Key words: comprehensive geriatric assessment; oncogeriatrics; cancer.Downloads
References
1 Bayarre Vea HD. Múltiples perspectivas para el análisis del envejecimiento demográfico. Una necesidad en el ámbito sanitario contemporáneo. Revista Cubana de Salud Pública [Internet]. 2018 [citado 1 sep 2020]; 43 (2): [Aprox. 3 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-346620170002000141.
2 Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol 2015;26(6):1091-101.
3.Schiefen JK, Madsen TL, Dains J. Instruments That Predict Oncology Treatment Risk in the Senior Population AdvPractOncol 2017;8:528–533https://doi.org/10.6004/jadpro.2017.8.5.8
4. Lim E, Vardy JL, Oh B, Dhillon HM. Integration of complementary andalternative medicine into cancer-specific supportive care programs inAustralia: a scoping study. Asia Pac J ClinOncol. 2017;13(1):6–12.
5. RaoAV,Hurria A, Kimmick G, Pinheiro S, Seo Ph. Geriatric oncolog: past, present, future. J OncoloPract J Oncol Pract. 2008 Jul; 4(4): 190–192. doi: 10.1200/JOP.0846001
6. DuMontier C, Sedrak M:S, Soo WK, Kenis C; Williams GR; Haase K; et al., ArtiHurria and the progress in integrating the geriatric assessment into oncology: Young international. J Geriatr Oncol . 2020 Mar;11(2):203-211. doi: 10.1016/j.jgo.2019.08.005.
7 Extermann M, Hurria A. Comprehensive Geriatric Assessment for Older Patients with Cancer. J ClinOncol 2007; 25:1824-1831.
8. KrocK Ł; SochaB. K SołtysikA. Cieślak-SkubelE.Piechocka-WochniakR,BłaszczakT. et al.Validation of the Vulnerable Elders Survey-13 (VES-13) in hospitalized older patients. European Geriatric. 2016;7(5):449-53
9. Pottel L, Lycke M, Boterberg T. G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy. BMC Cancer 2015;15: 875.
10. Romero-Cabrera Á, Amores-Hernández L, Cardona-Alfonso Y. Evaluación geriátrica hospitalaria: una herramienta necesaria. Medisur[revista en Internet]. 2018 [citado 5/7/2020]; 16(5): [aprox. 22 p.]
11. Kalsi T, Babic-Illman G, Ross PJ. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. Br J Cancer 2015; 112:1435–44.
12. Lowenstein LM, Mohile SG, Gil H. Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study. J GeriatrOncol 2016; 7:437–43.
13. Saliba D , Elliott M, Rubenstein LZ, Solomon DH, Young R T, Kamberg CJ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community J Am Geriatr Soc.2001 Dec;49(12):1691-9. doi: 10.1046/j.1532-5415.2001.49281.x
14. Clinical Practice guidelines in oncology (NCCN guidelines) Older adult Oncology version 1.2019-january 2019. disponible en: www.nccn.org
15. Lawton, M.P., & Brody, E.M. Assessment ofolderpeople: Self-maintaining and instrumental activitiesofdaily living. TheGerontologist(1969); 9(3), 179-186
15. Baldacci L, Extermann M. Magement of the frail person with advanced cancer. CritOncolHematol 2000; 33:143-48.
16. Decoster L, Van Puyvelde K, Mohile S. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 2015; 16:288–300.
17. Mohile SG, Velarde C, Hurria A, Magnuson A, Lowenstein L, Pandya C, et al. Geriatric Assesment-guided care processes for older adults: a Delphi consensus of Geriatric Oncology experts. J NatlComprCancNetw 2015;13(9):1120-30.
18. RubliTruchard: Geriatric palliative care: a view of its concept, challenges and strategies; BMC Geriatr. 2018; 18: 220.
19.Souberan P, BelleraC,Goyard J.Screenig forvulnerability in older cancer patientes:the ONCODAGE. Prospective Multicenter Cohort Study. Plos One 2014,9 e 115060
20. Molina-Garrido MJ, Guillén-Ponce C. Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review, The Aging Male (2017); 20:2, 102-109, DOI: 10.1080/13685538.2016.1277516
21. Dent E, Wright O, Hoogendijk EO, Hubbard RE. Nutritional screening and dietitian consultation rates in a geriatric evaluation and management unit. Nutr Diet 2018; 75 (1): 11-16.
22. Rubenstein LZ, Harker JC, Guigoz Y, Vellas B. Screning for Under nutrition in Geriatric Practice: Developing the short- form Mini Nutritional Assessment. J Gerontol A BiolSci Med Sci 2001;56:M366-M372
23. Huisingh-Scheetz M, Walston J. How should older adults with cancer be evaluated for frailty?JGeriatrOncol. 2017 January; 8(1): 8–15. doi: 10.1016/j.jgo.2016.06.003.
24. Flores Nuñez D.Evaluación geriátrica integral en adultos mayores con cáncer.Revista Clínica de la Escuela de Medicina UCR 2017;Vol 7 (III):11-15 DOI 10.15517/rc_ucr-hsjd.v7i3.30018
25. Benavides-Caro CA. Deterioro cognitivo en el adulto mayor. Revista mexicana de anestesiología. 2017;40(2):107-12
26. Gálvez-Cano M, Chávez-Jimeno H, Aliaga-Diaz E. Utilidad de la valoración geriátrica integral en la evaluación de la salud del adulto mayor. Rev Peru Med Exp Salud Pública. 2016; 33(2):321-7. doi: 10.17843/rpmesp.2016.332.2204
27. Molina-Garrido MJ, Soriano Rodríguez MC, Muñoz Sánchez MM.Oncogeriatría: manejo del enfermo con comorbilidades y con polifarmacia. Interacciones farmacológicas En: manual de cuidados continuos. Camps Herrero C (Ed) 3ra Edicion. España 2019 pp263-270.
28. Palm R, Jünger S, Reuther S, Christian G, Schwab G, Martin N,et al. People with dementia in nursing homeresearch: a methodological review of thedefinition and identification of the studypopulation BMC Geriatrics (2016) 16:78 DOI 10.1186/s12877-016-0249-7
29. Blanco Aspiazu MA, Shunchao K, XueqingL. La comorbilidad y su valor para el médico generalista en Medicina Interna. Revista Habanera de Ciencias Médicas [revista en Internet]. 2017 [citado 2020 dic 8];16(1):[aprox. 0 p.]. Disponible en:http://www.revhabanera.sld.cu/index.php/rhab/article/view/1475Re
30. Ryan DJ, O´Sullivan F, Jackson SHD. Prescribing medicines for older patients. Medicine. 2016; 44 (7): 433-7.
31. Miller MD, Tower A. A Manual of guidelines for scoring the cumulative Illness rating sacleforgeriatrics (CIRGS-G). MAY1991
32.Schiefen JK, Madsen TL, Dains J. Instruments That Predict Oncology Treatment Risk in the Senior Population AdvPractOncol 2017;8:528–533https://doi.org/10.6004/jadpro.2017.8.5.8
33. Hurria A, Mohile S, Gajra A, Klepin H, Muss H, Chapman A et al. Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J ClinOncol. 2016;34(20):2366-71.
34.
35. Obreli-Neto PR, Nobili A, Marusic S. Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the Brazilian primary public health system. J Pharm PharmaceutSci [Internet]. 2012 [citado 11/09/2016];15(2):344-54. Disponible en: https://ejournals.library.ualberta.ca/index.php/JPPS/ article/viewFile/12209/13688 [ Links ]
36. Extermann M, Bonetti M, Sledge GW, O’Dwyer PJ, Bonomi P, Benson AB 3rd., MAX2—a convenient index to estimate the average per patient risk for chemotherapy toxicity;validation in ECOG trials. Eur J Cancer. 2004;40:1193-
1198.
37. Extermann M, Boler I, Reich R, Lyman G, Brown R, De Felice J, et al. Predicting the Risk of Chemotherapy Toxicity in Older Patients: The Chemotherapy Risk Assessment Scale for High-Age Patients(CRASH) Store. CancerJuly 1, 2012 DOI: 10.1002/cncr.26646
Downloads
Published
How to Cite
Issue
Section
License
Esta revista provee acceso libre e inmediato a su contenido bajo el principio de que hacer disponible gratuitamente la investigación al público apoya a un mayor intercambio de conocimiento global.
Esto significa que se permite su copia y distribución por cualquier medio siempre que mantenga el reconocimiento de sus autores, no haga uso comercial de las obras y no realice ninguna modificación de ellas.
El envío de manuscritos, el procesamiento y la publicación no ofrece ningún coste a los autores, es totalmente gratis.
